Single-arm phase II study of panitumumab rechallenge in combination with oxaliplatin or irinotecan-based chemotherapy in patients with RAS wild type advanced colorectal cancer.
Phase of Trial: Phase II
Latest Information Update: 20 Nov 2018
At a glance
- Drugs Panitumumab (Primary) ; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 28 Nov 2017 Status changed from not yet recruiting to recruiting.
- 02 Sep 2017 New trial record